Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/INO
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Inovio Pharmaceuticals Inc (INO) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

INO Pharmaceuticals trades at $0.677, down 34.9% in the last session, reflecting significant bearish pressure. The stock shows extremely negative technical signals with all moving averages bearish and RSI levels near oversold territory. Fundamentally, the company faces severe challenges with minimal revenue of $65,340 against massive losses, negative margins exceeding -130,000%, and consistent cash burn. Recent news highlights a $20 million public offering and ongoing FDA review of INO-3107, creating a binary event risk for October 2026.
The investment case hinges entirely on FDA approval of INO-3107 in October 2026, representing a high-risk binary event. While analyst sentiment leans bullish with 53% buy ratings, the company's financial instability and negative cash flow pose substantial risks. Success could drive significant upside, but failure may threaten ongoing operations given the current cash position funding operations only into early 2027.
Read full analysis

Key Stats

  • Market Cap
    $55.70M
  • Volume
    -
  • Sector
    Health
  • 52W High
    $2.87
  • 52W Low
    $0.66
  • Typical Hold Time
    -
  • Enterprise Value
    $26.71M
  • Div Yield
    -
  • Trading Activity
    -
$0.68
52W Low: $0.66
30 Jul 2026
52W High: $2.87
08 Sep 2025

Track Inovio Pharmaceuticals Inc (INO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Inovio Pharmaceuticals Inc has traded between a low of $0.66 and a high of $2.87, highlighting its annual price range. Buy and sell Inovio Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Most Recent News

Content is generated by Aura AI

Stock faces skepticism over costly discovery but holds cash from midstream asset sale, eyes operational improvements.

The article discusses a stock currently viewed skeptically by the market due to a recent high-cost discovery. Despite this, the company has significant cash reserves from selling a noncontrolling interest in a Western Haynesville midstream company. M...

Market News
4 hours ago
Seeking Alpha
Neutral
pluang ai news

Microsoft posts record Q4 with 43% Azure growth, shares could hit $600 in 2-3 years

Microsoft reported record Q4 results with Azure revenue growing 43% and total revenue hitting $90 billion, easing concerns about high AI-related spending. Despite near-term margin pressure from increased capital expenditures, strong cloud growth and ...

Company Fundamentals
4 hours ago
Seeking Alpha
Bullish
news icon
pluang ai news

Amazon may hit $5 trillion market cap by mid-2028, driven by strong AWS and AI growth.

Amazon's market value reached about $2.92 trillion after strong Q2 2026 results, with ChatGPT forecasting a $5 trillion valuation by mid-2028 based on continued growth in AWS, advertising, and AI. AWS revenue grew 37% annually, and Amazon's AI and cu...

Market News
4 hours ago
Finbold
Bullish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $55.70M
  • Volume
    -
  • Sector
    Health
  • 52W High
    $2.87
  • 52W Low
    $0.66
  • Typical Hold Time
    -
  • Enterprise Value
    $26.71M
  • Div Yield
    -
  • Trading Activity
    -
$0.68
52W Low: $0.66
30 Jul 2026
52W High: $2.87
08 Sep 2025

Track Inovio Pharmaceuticals Inc (INO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Inovio Pharmaceuticals Inc has traded between a low of $0.66 and a high of $2.87, highlighting its annual price range. Buy and sell Inovio Pharmaceuticals Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!